PAHC - PHIBRO ANIMAL HEALTH CORP
51.89
-0.380 -0.732%
Share volume: 166,560
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.74%
PREVIOUS CLOSE
CHG
CHG%
$52.27
-0.26
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 05-08-2024 | 01-07-2025 | 11-06-2024 | 02-05-2025 | 05-07-2025 | 08-27-2025 | 11-05-2025 | 02-04-2026 | |
| Assets | |||||||||
| Total Assets | 979.035 M | 982.184 M | 966.289 M | 1.286 B | 1.317 B | 1.361 B | 1.386 B | 1.406 B | |
| Current Assets | 597.180 M | 600.997 M | 570.767 M | 746.153 M | 776.018 M | 810.606 M | 835.799 M | 862.185 M | |
| Inventories | 282.289 M | 265.911 M | 272.556 M | 427.224 M | 448.390 M | 444.425 M | 471.775 M | 517.347 M | |
| Other Current Assets | 55.056 M | 51.021 M | 47.597 M | 60.066 M | 59.756 M | 61.159 M | 60.855 M | 54.458 M | |
| Short Term Investments | 48.523 M | 44.000 M | 38.000 M | 0.000 | 10.000 M | 9.000 M | 12.504 M | 19.022 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 50.225 M | 70.613 M | 51.837 M | 67.074 M | 60.354 M | 68.039 M | 72.769 M | 55.486 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 202.061 M | 203.300 M | 206.315 M | 337.662 M | 336.093 M | 354.690 M | 354.780 M | 355.381 M | |
| Other Assets | 179.794 M | 177.887 M | 189.207 M | 201.694 M | 205.149 M | 195.604 M | 194.945 M | 187.987 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 979.035 M | 982.184 M | 966.289 M | 1.286 B | 1.317 B | 1.361 B | 1.386 B | 1.406 B | |
| Total liabilities | 708.941 M | 725.543 M | 707.762 M | 1.039 B | 1.051 B | 1.075 B | 1.074 B | 1.073 B | |
| Total current liabilities | 189.072 M | 204.148 M | 176.894 M | 233.250 M | 266.481 M | 293.473 M | 270.139 M | 282.370 M | |
| Accounts Payable | 82.613 M | 85.567 M | 86.528 M | 99.445 M | 131.622 M | 138.201 M | 130.597 M | 133.296 M | |
| Other liabilities | 63.861 M | 63.106 M | 64.200 M | 68.577 M | 73.630 M | 79.310 M | 79.186 M | 80.220 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 456.008 M | 458.289 M | 466.668 M | 736.880 M | 711.157 M | 702.435 M | 724.518 M | 710.602 M | |
| Other liabilities | 63.861 M | 63.106 M | 64.200 M | 68.577 M | 73.630 M | 79.310 M | 79.186 M | 80.220 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 270.094 M | 256.641 M | 258.527 M | 246.802 M | 265.992 M | 285.682 M | 311.681 M | 332.361 M | |
| Common stock | 136.103 M | 136.282 M | 136.461 M | 136.641 M | 136.820 M | 136.999 M | 137.338 M | 137.772 M | |
| Retained earnings | 247.995 M | 243.886 M | 246.001 M | 244.326 M | 260.341 M | 272.701 M | 294.364 M | 316.959 M |